These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 4634627)
21. FDA inspections of large volume and small volume parenteral manufacturers. Shepherd RE Bull Parenter Drug Assoc; 1976; 30(5):209-13. PubMed ID: 974306 [No Abstract] [Full Text] [Related]
22. Benefits and liabilities of generic prescribing. Lee AM W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384 [No Abstract] [Full Text] [Related]
23. FDA approvals. New drugs, new uses. Rodman MJ RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204 [No Abstract] [Full Text] [Related]
26. Dealing with drug advertising. The FDA can't always enforce the rules on misleading ads. Atkinson HG Health News; 2003 Feb; 9(2):5. PubMed ID: 12632541 [No Abstract] [Full Text] [Related]
27. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related]
28. The FDA and the fight against terrorism. Meadows M FDA Consum; 2004; 38(1):20-7. PubMed ID: 15032200 [No Abstract] [Full Text] [Related]
29. Realizing two-tiered innovation policy through drug regulation. Ridgway WE Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807 [No Abstract] [Full Text] [Related]
30. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
31. Does the FDA have authority to regulate human cloning? Price EC Harv J Law Technol; 1998; 11(3):619-41. PubMed ID: 12731551 [No Abstract] [Full Text] [Related]
32. The FDA advances scientific research. FDA Consum; 2006; 40(2):5. PubMed ID: 16673452 [No Abstract] [Full Text] [Related]
33. FDA attempting to overcome major roadblocks in monitoring drug safety. Zielinski SL J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645 [No Abstract] [Full Text] [Related]
34. FDA implementation of standards developed by the International Conference on Harmonisation. Booth PM Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561 [No Abstract] [Full Text] [Related]
35. The FDA and Helsinki. Rennie S Hastings Cent Rep; 2009; 39(3):49. PubMed ID: 19537622 [No Abstract] [Full Text] [Related]
36. FDA reiterates warning against online drug buying. Rados C FDA Consum; 2004; 38(5):17. PubMed ID: 15595143 [No Abstract] [Full Text] [Related]
37. Pharmacological and safety aspects of existing requirements and regulations when introducing a new drug. Kramer M Arzneimittelforschung; 1974 Apr; 24(4):504-8. PubMed ID: 4408328 [No Abstract] [Full Text] [Related]
38. The drug efficacy study. Provost GP Am J Hosp Pharm; 1968 Sep; 25(9):483. PubMed ID: 5671558 [No Abstract] [Full Text] [Related]
39. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages. Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586 [No Abstract] [Full Text] [Related]
40. FDA cracks down on labeling, initiates trial result reporting. Osborne R; Waltz E Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]